Multiorgan sensitivity to anticarcinogenesis by the organoselenium 1,4-phenylenebis(methylene)selenocyanate

Nutrition and Cancer

Volumn 40, Issue 1, 2001, Pages 18-27

  El Bayoumy, K ^a   Rao, C V ^a   Reddy, B S ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; BENZYL SELENOCYANATE; BENZYL THIOCYANATE; ORGANOSELENIUM DERIVATIVE; SELENOL DERIVATIVE; SELENOMETHIONINE; SELENOMETHYLSELENOCYSTEINE; SODIUM SELENITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLON CANCER; CONTROLLED STUDY; DRUG METABOLISM; DRUG SENSITIVITY; LUNG CANCER; MALE; METASTASIS; MOUTH CANCER; NONHUMAN; RAT; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0035679736     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC401_6     Document Type: Review

References (60)

1. Nature and nurture: Possibilities for cancer control
2. Dietary control of cancer
3. Selenium and cancer
4. The role of selenium in cancer prevention
5. Chemoprevention of cancer by organoselenium compounds
6. Possible protective effect of selenium against human cancer
7. Cancer mortality correlation studies. III. Statistical association with dietary selenium intakes
8. Selenium in forage crops and cancer mortality in US counties
9. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial
10. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial
11. The importance of selenium to human health
12. Lessons from basic research in selenium and cancer prevention
13. Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer
14. Chemoprevention of mammary cancer by diallyl selenide, a novel organoselenium compound
15. Inhibition of 7,12-dimethylbenz[a]anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate
16. The effects of 1-nitropyrene,2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene on 8-hydroxy-2′-deoxyguanosine levels in the rat mammary gland and modulation by dietary 1,4-phenylenebis(methylene)selenocyanate
17. Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention
18. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line
19. Selenium and mouse mammary tumorigenesis, an investigation on possible mechanisms
20. Inhibition of thymidine kinase in cultured mammary tumor cells by the chemopreventive organoselenium compound 1,4-phenylenebis(methylene)selenocyanate
21. Effects of organic and inorganic selenium compounds on rat mammary tumor cells
22. Effects of chemopreventive selenium compounds on Jun N-kinase activities
23. Cancer statistics, 1999
24. Effect of dietary benzylselenocyanate on azoxymethane-induced colon carcinogenesis in male F344 rats
25. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate
26. Chemoprevention of colon cancer by synthetic organoselenium compounds, 1,4-phenylenebis(methylene)selenocyanate and p-methoxy benzyl selenocyanate, in low and/or high fat fed F344 rats
27. Lack of chemopreventive efficacy of DL-selenomethionine in colon carcinogenesis
28. The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate
29. Cancer-susceptibility genes. Gatekeepers and caretakers
30. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse
31. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
32. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma
33. min mouse model by 1,4-phenylenebis(methylene)selenocyanate
34. Smoking and lung cancer: Scientific challenges and opportunities
35. Estimates of the worldwide incidence of 18 major cancers in 1985
36. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines
37. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone tumorigenicity in mouse lung by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate
38. Effects of 1,4-phenylenebis(methylene)selenocyanate and selenomethionine on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mouse lung
39. Effects of dietary 1,4-phenylenebis(methylene)selenocyanate on 4-(methyl-nitrosamino)-1-(3-pyridyl)-l-butanone-induced DNA adduct formation in lung and liver of A/J mice and F344 rats
40. Elevated 8-hydroxy-2′-deoxyguanosine levels in lung DNA of A/J mice and F344 rats treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and inhibition by dietary 1,4-phenylenebis(methylene)selenocyanate
41. Chemoprevention of lung tumorigenesis induced by a mixture of benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate
42. Nutrition and tobacco-related cancer
43. Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early-stage disease
44. Chemoprevention of oral carcinogenesis
45. 1,4-Phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis
46. The evolution of biological heterogeneity in metastatic neoplasms
47. Critical determinants of cancer metastasis: Rationale for therapy
48. Effect of dietary supplementation of selenite on pulmonary metastasis of melanoma cells in mice
49. Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice
50. Suppressing effects of dietary supplementation of the organoselenium 1,4-phenylenebis(methylene)selenocyanate and the citrus antioxidant auraptene on lung metastasis of melanoma cells in mice
51. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase
52. In vitro and in vivo studies of methylseleninic acid: Evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention
53. 14C]benzyl selenocyanate in the F344 rat
54. Identification and metabolism of selenocysteine-glutathione selenenyl sulfide (CySeSG) in small intestine of mice orally exposed to selenocystine
55. Evaluation of benzyl selenocyanate glutathione conjugate for potential chemopreventive properties in colon carcinogenesis
56. 14C]phenylenebis(methylene)selenocyanate in the rat
57. Dissociation of the genotoxic and growth inhibitory effects of selenium
58. Activities of structurally related lipophilic selenium compounds as cancer chemopreventive agents